Advancing the Science of Immuno-Oncology

The Company
Aptevo Therapeutics is a biotech company focused on bringing novel immuno-oncology therapeutics to market. We leverage the innovative and proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies to create therapeutic candidates designed to improve outcomes for cancer patients.

Based in Seattle, Washington, the company is notable for its empowering work environment, entrepreneurial culture, proprietary platform technologies and success in recruiting some of the most innovative minds in the industry.

The Pipeline
Two clinical candidates. Three preclinical candidates. All in development to improve outcomes for cancer patients.

Pipeline Provides Multiple Shots on Goal

Aptevo Pipeline

The Platforms

ADAPTIR™ and ADAPTIR-FLEX™: Science for the Future of Cancer Treatment

The Company’s proprietary platforms and clinical programs provide opportunities for a broad range of potential partnering and licensing arrangements, which may include upfront fees, development milestones, royalties and other compensation.

Our core values of ownership and collaboration—combined with a history of innovation, dedication, and development expertise — position the Company to define the science of what’s next in immuno-oncology.

Learn more about our Management Team and Board of Directors.